Literature DB >> 1785097

Salvage and reconstructive surgery for spinal deformity using Cotrel-Dubousset instrumentation.

R B Winter1, F Denis, J E Lonstein, E Dezen.   

Abstract

Sixty consecutive patients who underwent Cotrel-Dubousset instrumentation as part of their reconstructive surgery (failure of previous surgery) were reviewed. The average follow-up was 3 years (range, 2-4.5 years). There were no deaths or major neurologic problems. Pseudarthrosis occurred in six patients, all of whom had long fusion to the sacrum; all six were successfully repaired. Cotrel-Dubousset instrumentation provides a far superior method of correction of deformity and internal fixation than that available previously.

Entities:  

Mesh:

Year:  1991        PMID: 1785097

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Predictive factors for a distal adjacent disorder with L3 as the lowest instrumented vertebra in Lenke 5C patients.

Authors:  Kei Ando; Shiro Imagama; Zenya Ito; Kazuyoshi Kobayashi; Tetsuro Hida; Kenyu Ito; Akito Tsushima; Yoshimoto Ishikawa; Akiyuki Matsumoto; Yoshihiro Nishida; Naoki Ishiguro
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-01

2.  Complications in patients undergoing combined transforaminal lumbar interbody fusion and posterior instrumentation with deformity correction for degenerative scoliosis and spinal stenosis.

Authors:  Sigita Burneikiene; E Lee Nelson; Alexander Mason; Sharad Rajpal; Benjamin Serxner; Alan T Villavicencio
Journal:  Surg Neurol Int       Date:  2012-02-15

3.  Radiographic and clinical outcomes following MIS-TLIF in patients with adult lumbar degenerative scoliosis.

Authors:  Yongfei Zhao; Yan Liang; Keya Mao
Journal:  J Orthop Surg Res       Date:  2018-04-19       Impact factor: 2.359

4.  A hybrid therapeutic approach for decreasing postoperative complications in patients with adult lumbar degenerative scoliosis.

Authors:  Yongfei Zhao; Yan Liang; Tianhao Wang; Zheng Wang; Ning Lu
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.